Beam Therapeutics Inc. — Form D/A
Beam Therapeutics Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2019-03-26. The offering totals $83.6M, of which $83.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-03-26
- Form: D/A
- Accession: 0001745999-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $83.6M
- Amount sold: $83.6M
- Investors: 21
- Date of first sale: 2018-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-318897
Issuer
- Name: Beam Therapeutics Inc.
- CIK: 0001745999
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Phone: 857-327-8775
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Robert Nelson | Director | Shreveport, LA |
| Robert Nelsen | Director | Seattle, WA |
| Kristina Burow | Director | San Diego, CA |
| Mark Fishman | Director | Oakland, CA |
| Stephen Knight | Director | NEW HAVEN, CT |
| John Evans | Director | West Haven, CT |
| John Evans | Executive Officer | West Haven, CT |
| Feng Zhang | Director | Qingdao, F4 |
| Michael Yi | Director | South San Francisco, CA |
| CAROLE HO | Director | CAMBRIDGE, MA |
Other filings by this issuer (2)
More